MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in ...

A new study has found that 10-hydroxy-cis-12-octadecenoic acid (HYA), a metabolite derived from linoleic acid by gut microbiota, can help reduce postprandial hyperglycemia (high blood sugar after ...

More than 36 million Americans have type 2 diabetes, meaning their blood sugar levels are always top of mind. After all, when people with diabetes have blood sugar levels that are too low or too high, ...

Type 2 diabetes (T2D) may impair reward processing in the brain, as shown in a rat maze experiment. Rats with T2D exhibited weaker reward signals in the anterior cingulate cortex (ACC) and spent ...

Scientists have described onion as the cheapest and most easily available treatment for diabetes. Researchers said that they did this study on rats and got amazing results in it. The results of ...

MIRA Pharmaceuticals (MIRA) announced data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of ...

In results published today in the Royal Society of Chemistry journal Biomaterials Science, researchers show that the insulin-loaded gel reduces blood glucose levels over 24 hours in a diabetic-rat ...

In the study, Type 2 diabetes was induced in rats using a high-fat diet combined with a low dose of Streptozotocin (STZ). This resulted in hyperglycemia and neuropathic symptoms, including ...

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...